MSFinals-0450

MSFinals-0450

In a randomized controlled trial evaluating the effectiveness of a new antihypertensive medication compared to conventional therapy for secondary stroke prevention in elderly patients, the researchers found a 0.5% reduction in the annual incidence of stroke. The cost of the new treatment is £100 more per patient per year than the conventional therapy. What is the cost per stroke prevented with the implementation of the new therapy?